language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
CVSCVS

$79.395

-0.87
arrow_drop_down1.08%
Current Market·update13 Nov 2025 17:59
Day's Range
78.52-79.99
52-week Range
43.56-85.15

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date2025-10-29
Next Earnings TimeBefore Market Open
Volume2.91M
Average Volume 30d7.37M

AI CVS Summary

Powered by LiveAI
💰
21.2
Valuation (P/E Ratio)
TTM P/E is 21.2, consider industry peers for context.
📈
0.152
EPS Growth (YoY)
Positive EPS surprises in recent quarters.
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Buy
68

CVS Health demonstrates a mixed but generally positive investment profile. While the company has a stable dividend and is involved in essential healthcare services, its recent performance shows some pressure, and near-term technicals suggest caution. The company's large scale and diversified operations provide a degree of resilience.

Moderate

Thematic

70

CVS Health operates within the defensive healthcare sector, benefiting from consistent demand for its pharmacy, insurance, and healthcare services. Trends like an aging population and increasing healthcare spending provide a stable, albeit not explosive, growth backdrop.

Stable

Fundamental

72

CVS Health exhibits a solid, albeit not spectacular, financial footing. Its revenue base is substantial, and it maintains a consistent dividend, but recent profitability has been under pressure, and debt levels are considerable.

Neutral to Cautious

Technical

55

The stock has experienced a significant decline recently, trading below key moving averages. While some oscillators suggest oversold conditions, the overall trend is bearish in the short to medium term, indicating potential for further downside or a period of consolidation.

FactorScore
Aging Population85
Healthcare Accessibility75
Managed Care Evolution60
Digital Health Integration70
Regulatory Headwinds50
FactorScore
Valuation70
Profitability40
Growth65
Balance Sheet Health55
Cash Flow60
Dividends85
FactorScore
Trend Analysis30
Momentum70
Volume Confirmation50
Support & Resistance60
MACD30

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (6)

Earnings Performance chevron_right

Positive Earnings Surprises

The company has exceeded earnings per share (EPS) estimates in the last four reported quarters, with surprises ranging from 3.54% to 32.07%. This indicates consistent operational efficiency and better-than-expected profitability.

Valuation chevron_right

Attractive P/E Ratio

The Price-to-Earnings (P/E) ratio on a trailing twelve months (TTM) basis is 21.2, which is favorable compared to the sector's average P/E ratio. This suggests the stock may be trading at a reasonable valuation relative to its earnings.

Show More 🔒
thumb_down

Bearish Points (7)

Valuation Risk chevron_right

High Quarterly P/E Ratio

The quarterly P/E ratios, particularly in Q1 2025 (47.2) and Q3 2024 (874.2), are significantly elevated. This suggests that recent earnings might be low relative to the stock price, potentially indicating overvaluation or short-term earnings volatility.

Growth Deceleration chevron_right

Slowing Revenue Growth

While annual revenue for 2024 reached $372.8 billion, quarterly revenue growth appears to be slowing or volatile, with Q3 2024 showing a net income margin of only 0.1%. This indicates potential pressure on top-line performance and profitability conversion.

Show More 🔒

Calendar

July 2025

22

Ex-Dividend Date

July 2025

31

Next Earnings Date

EPS Est.
Revenue Est.

H: $1.72

A: $1.46

L: $1.37

H: 98.80B

A: 94.59B

L: 91.19B

August 2025

1

Next Dividend Date

Profile

Employees (FY)219K
ISINUS1266501006
FIGI-

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Seasonals

2025
2024
2023
2022
2021

Price Target

79.45 USD

The 39 analysts offering 1 year price forecasts for CVS have a max estimate of 95.00 and a min estimate of 67.00.

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
1.26B (99.79%)
Closely held shares
2.63M (0.21%)
1.27B
Free Float shares
1.26B (99.79%)
Closely held shares
2.63M (0.21%)

Capital Structure

Market cap
74.32B
Debt
82.92B
Minority interest
0.00
Cash & equivalents
8.59B
Enterprise value
148.65B

Valuation - Summary

Market Cap
74.3B
Net income
3.51B(4.72%)
Revenue
288B(387.15%)
74.3B
Market Cap
74.3B
Net income
3.51B(4.72%)
Revenue
288B(387.15%)
Price to earning ratio (P/E)21.20x
Price to sales ratio (P/S)0.30x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
372.81B
COGS
321.41B
Gross Profit
51.4B
OpEx
41.61B
Operating Income
9.79B
Other & Taxes
5.18B
Net Income
4.61B

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒